Topiramate - NDC Database (Page 25)
70710-1039 Jan 17, 2023
Topiramate 25 mg Oral Capsule, Extended Release by Zydus Pharmaceuticals USA Inc.
Topiramate 25 mg Oral Capsule, Extended Release by Zydus Pharmaceuticals USA Inc.
70710-1040 Jan 17, 2023
Topiramate 50 mg Oral Capsule, Extended Release by Zydus Pharmaceuticals USA Inc.
Topiramate 50 mg Oral Capsule, Extended Release by Zydus Pharmaceuticals USA Inc.
70710-1041 Jan 17, 2023
Topiramate 100 mg Oral Capsule, Extended Release by Zydus Pharmaceuticals USA Inc.
Topiramate 100 mg Oral Capsule, Extended Release by Zydus Pharmaceuticals USA Inc.
70710-1042 Jan 17, 2023
Topiramate 150 mg Oral Capsule, Extended Release by Zydus Pharmaceuticals USA Inc.
Topiramate 150 mg Oral Capsule, Extended Release by Zydus Pharmaceuticals USA Inc.
70710-1043 Jan 17, 2023
Topiramate 200 mg Oral Capsule, Extended Release by Zydus Pharmaceuticals USA Inc.
Topiramate 200 mg Oral Capsule, Extended Release by Zydus Pharmaceuticals USA Inc.
70748-275 Feb 03, 2026
Topiramate 25 mg Oral Capsule, Extended Release by Lupin Pharmaceuticals, Inc.
Topiramate 25 mg Oral Capsule, Extended Release by Lupin Pharmaceuticals, Inc.
70748-276 Feb 03, 2026
Topiramate 50 mg Oral Capsule, Extended Release by Lupin Pharmaceuticals, Inc.
Topiramate 50 mg Oral Capsule, Extended Release by Lupin Pharmaceuticals, Inc.
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.